ABBOTT XIENCE V® Everolimus-Eluting Coronary Stent System – Advanced Drug-Eluting Stent for Coronary Artery Disease

SKU
KES-ABBOTT-0020
-11%
Special Price ₹23,406.04 was ₹26,152.00
In stock
  • Brand: Abbott
  • Product Name: XIENCE V® Everolimus-Eluting Coronary Stent System
  • Category: Interventional Cardiology
  • Usage: Designed to improve coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions. The stent releases everolimus, an antiproliferative drug, to prevent restenosis by inhibiting neointimal tissue growth.
  • Features:
    • Stent Composition: Constructed from cobalt-chromium (CoCr) alloy, providing strength and radiopacity with a thin strut design for enhanced deliverability.
    • Drug Coating: Utilizes a durable fluoropolymer coating that controls the release of everolimus, promoting effective suppression of neointimal proliferation while facilitating rapid endothelialization.
    • Clinical Efficacy: Demonstrated reduced rates of repeat revascularization, myocardial infarction, and stent thrombosis at 1-year follow-up compared to first-generation drug-eluting stents.
    • Indications: Approved for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (lesions ≤28 mm) with reference vessel diameters of 2.25 mm to 4.25 mm
BrandAbbott